nach oben

Erschienen in:

01.02.2013 | Original paper

Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population

verfasst von: Aruna Kamineni, Melissa L. Anderson, Emily White, Stephen H. Taplin, Peggy Porter, Rachel Ballard-Barbash, Kathleen Malone, Diana S. M. Buist

Erschienen in: Cancer Causes & Control | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Many studies suggest increased body mass index (BMI) is associated with worse breast cancer outcomes, but few account for variability in screening, access to treatment, and tumor differences. We examined the association between BMI and risk of breast cancer recurrence, breast cancer-specific mortality, and all-cause mortality, and evaluated whether tumor characteristics differ by BMI among a mammographically screened population with access to treatment.

Methods

Using a retrospective cohort study design, we followed 485 women aged ≥40 years diagnosed with stage I/II breast cancer within 24 months of a screening mammogram occurring between 1988 and 1993 for 10-year outcomes. BMI before diagnosis was categorized as normal (<25 kg/m²), overweight (25–29.9 kg/m²), and obese (≥30 kg/m²). Tumor marker expression was assessed via immunohistochemistry using tissue collected before adjuvant treatment. Medical records were abstracted to identify treatment, recurrence, and mortality. We used Cox proportional hazards to separately model the hazard ratios (HR) of our three outcomes by BMI while adjusting for age, stage, and tamoxifen use.

Results

Relative to normal-weight women, obese women experienced increased risk of recurrence (HR 2.43; 95 % CI 1.34–4.41) and breast cancer death (HR 2.41; 95 % CI 1.00–5.81) within 10 years of diagnosis. There was no association between BMI and all-cause mortality. Obese women had significantly faster growing tumors, as measured by Ki-67.

Conclusions

Our findings add to the growing evidence that obesity may contribute to poorer breast cancer outcomes, and also suggest that increased tumor proliferation among obese women is a pathway that explains part of their excess risk of adverse outcomes.

Goodwin PJ, Boyd NF (1990) Body size and breast cancer prognosis: a critical review of the evidence. Breast Cancer Res Treat 16:205–214PubMedCrossRef

Greenberg ER, Vessey MP, McPherson K, Doll R, Yeates D (1985) Body size and survival in premenopausal breast cancer. Br J Cancer 51:691–697PubMedCrossRef

Holmberg L, Lund E, Bergstrom R, Adami HO, Meirik O (1994) Oral contraceptives and prognosis in breast cancer: effects of duration, latency, recency, age at first use and relation to parity and body mass index in young women with breast cancer. Eur J Cancer 30A:351–354PubMedCrossRef

Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL (2001) Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 92:720–729PubMedCrossRef

Zhang S, Folsom AR, Sellers TA, Kushi LH, Potter JD (1995) Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women’s Health Study. Cancer 76:275–283PubMedCrossRef

Chang S, Alderfer JR, Asmar L, Buzdar AU (2000) Inflammatory breast cancer survival: the role of obesity and menopausal status at diagnosis. Breast Cancer Res Treat 64:157–163PubMedCrossRef

Ewertz M, Jensen MB, Gunnarsdottir KA et al (2011) Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 29:25–31PubMedCrossRef

Senie RT, Rosen PP, Rhodes P, Lesser ML, Kinne DW (1992) Obesity at diagnosis of breast carcinoma influences duration of disease-free survival. Ann Intern Med 116:26–32PubMed

Chlebowski RT, Aiello E, McTiernan A (2002) Weight loss in breast cancer patient management. J Clin Oncol 20:1128–1143PubMedCrossRef

10.

Maehle BO, Tretli S (1996) Pre-morbid body-mass-index in breast cancer: reversed effect on survival in hormone receptor negative patients. Breast Cancer Res Treat 41:123–130PubMedCrossRef

11.

Newman SC, Lees AW, Jenkins HJ (1997) The effect of body mass index and oestrogen receptor level on survival of breast cancer patients. Int J Epidemiol 26:484–490PubMedCrossRef

12.

Williams G, Howell A, Jones M (1988) The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast. Br J Cancer 58:631–634PubMedCrossRef

13.

Obermair A, Kurz C, Hanzal E et al (1995) The influence of obesity on the disease-free survival in primary breast cancer. Anticancer Res 15:2265–2269PubMed

14.

Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP (2003) Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 95:1467–1476PubMedCrossRef

15.

den Tonkelaar I, de Waard F, Seidell JC, Fracheboud J (1995) Obesity and subcutaneous fat patterning in relation to survival of postmenopausal breast cancer patients participating in the DOM-project. Breast Cancer Res Treat 34:129–137CrossRef

16.

Katoh A, Watzlaf VJ, D’Amico F (1994) An examination of obesity and breast cancer survival in post-menopausal women. Br J Cancer 70:928–933PubMedCrossRef

17.

Carmichael AR, Bendall S, Lockerbie L, Prescott RJ, Bates T (2004) Does obesity compromise survival in women with breast cancer? Breast 13:93–96PubMedCrossRef

18.

Caan BJ, Emond JA, Natarajan L et al (2006) Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat 99:47–57PubMedCrossRef

19.

Taplin SH, Mandelson MT, Anderman C et al (1997) Mammography diffusion and trends in late-stage breast cancer: evaluating outcomes in a population. Cancer Epidemiol Biomarkers Prev 6:625–631PubMed

20.

Taplin SH, Thompson RS, Schnitzer F, Anderman C, Immanuel V (1990) Revisions in the risk-based Breast Cancer Screening Program at Group Health Cooperative. Cancer 66:812–818PubMedCrossRef

21.

Taplin SH, Ichikawa L, Yood MU et al (2004) Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst 96:1518–1527PubMedCrossRef

22.

Fleming ID, Cooper JS, Henson DE et al (eds) (1997) AJCC Cancer Staging Manual, 5th edn. Lippincott Williams & Wilkins, Philadelphia

23.

Buist DS, Porter PL, Lehman C, Taplin SH, White E (2004) Factors contributing to mammography failure in women aged 40–49 years. J Natl Cancer Inst 96:1432–1440PubMedCrossRef

24.

Porter PL, El-Bastawissi AY, Mandelson MT et al (1999) Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 91:2020–2028PubMedCrossRef

25.

WHO (2000) Obesity: preventing and managing the global epidemic. World Health Organization, Geneva (Switzerland)

26.

American College of Radiology (ACR) (2003) ACR BI-RADS—mammography ACR Breast Imaging and Reporting and Data System, Breast Imaging Atlas, 4th edn. American College of Radiology, Reston

27.

Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285:171–176PubMedCrossRef

28.

Buist DS, Chubak J, Prout M et al (2009) Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence. J Clin Oncol 27:4508–4514PubMedCrossRef

29.

Geiger AM, Thwin SS, Lash TL et al (2007) Recurrences and second primary breast cancers in older women with initial early-stage disease. Cancer 109:966–974PubMedCrossRef

30.

Yood MU, Owusu C, Buist DS et al (2008) Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg 206:66–75PubMedCrossRef

31.

Zou G (2004) A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159:702–706PubMedCrossRef

32.

Rosner GL, Hargis JB, Hollis DR et al (1996) Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541. J Clin Oncol 14:3000–3008PubMed

33.

Griggs JJ, Culakova E, Sorbero ME et al (2007) Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. J Clin Oncol 25:277–284PubMedCrossRef

34.

Mannisto S, Pietinen P, Pyy M, Palmgren J, Eskelinen M, Uusitupa M (1996) Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status. Int J Cancer 68:8–13PubMedCrossRef

35.

Ruder AM, Lubin F, Wax Y, Geier A, Alfundary E, Chetrit A (1989) Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences. Cancer 64:196–202PubMedCrossRef

36.

Giuffrida D, Lupo L, La Porta GA et al (1992) Relation between steroid receptor status and body weight in breast cancer patients. Eur J Cancer 28:112–115PubMedCrossRef

37.

Howson CP, Kinne D, Wynder EL (1986) Body weight, serum cholesterol, and stage of primary breast cancer. Cancer 58:2372–2381PubMedCrossRef

38.

Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L (2000) Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev 9:681–687PubMed

39.

Elmore JG, Carney PA, Abraham LA et al (2004) The association between obesity and screening mammography accuracy. Arch Intern Med 164:1140–1147PubMedCrossRef

40.

Carney PA, Harwood BG, Weiss JE, Eliassen MS, Goodrich ME (2002) Factors associated with interval adherence to mammography screening in a population-based sample of New Hampshire women. Cancer 95:219–227PubMedCrossRef

41.

Fontaine KR, Heo M, Allison DB (2001) Body weight and cancer screening among women. J Womens Health Gend Based Med 10:463–470PubMedCrossRef

42.

Wee CC, McCarthy EP, Davis RB, Phillips RS (2000) Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? Ann Intern Med 132:697–704PubMed

43.

Caan BJ, Aragaki A, Thomson CA et al (2009) Vasomotor symptoms, adoption of a low-fat dietary pattern, and risk of invasive breast cancer: a secondary analysis of the Women’s Health Initiative randomized controlled dietary modification trial. J Clin Oncol 27:4500–4507PubMedCrossRef

44.

Kaplan MA, Pekkolay Z, Kucukoner M et al (2012) Type 2 diabetes mellitus and prognosis in early stage breast cancer women. Med Oncol 29:1576–1580PubMedCrossRef

45.

Patterson RE, Flatt SW, Saquib N et al (2010) Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat 122:859–865PubMedCrossRef

46.

Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2008) The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat 109:389–395PubMedCrossRef

47.

National Comprehensive Cancer Network (2012) NCCN clinical practice guidelines in oncology (NCCN guidelines) breast cancer version 3, 2012th edn. National Comprehensive Cancer Network, Fort Washington

48.

Nekhlyudov L, Li L, Ross-Degnan D, Wagner AK (2011) Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer. Breast Cancer Res Treat 130:681–689PubMedCrossRef

Titel: Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population
verfasst von: Aruna Kamineni
Melissa L. Anderson
Emily White
Stephen H. Taplin
Peggy Porter
Rachel Ballard-Barbash
Kathleen Malone
Diana S. M. Buist
Publikationsdatum: 01.02.2013
Verlag: Springer Netherlands
Erschienen in: Cancer Causes & Control / Ausgabe 2/2013
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-012-0115-7

Springer Medizin

Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population